R&D, Pharmacovigilance & Regulatory Affairs
R&D, Pharmacovilance & Regulatory Affairs
Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
| Title | Location |
Date
|
Req ID | |
|---|---|---|---|---|
|
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Europe, IT
Jun 12, 2026
6111
|
||||
|
Specialist, Labelling & Compliance Regulatory Affairs, Global Rare Diseases
Parma, IT
Jun 12, 2026
7364
|
||||
|
Manager, EU & International Regulatory Affairs, Global Rare Diseases
Parma or Dublin, IT
Jun 12, 2026
7302
|
||||
|
Master's thesis in computational modelling of aerosol deposition in respiratory system
Parma, IT
Jun 8, 2026
6598
|
||||